NF-κB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells

Cellular Signalling

Volumn 19, Issue 5, 2007, Pages 1093-1100

  Lessard, Laurent ^a   Saad, Fred ^a   Le Page, Cécile ^a   Diallo, Jean Simon ^a   Péant, Benjamin ^a   Delvoye, Nathalie ^a   Mes Masson, Anne Marie ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Androgen receptor; LNCaP; NF kappaB; Prostate cancer; Signalling

Indexed keywords

ANDROGEN; DNA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METRIBOLONE; PROTEIN P50; PROTEIN P52; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; ANDROGEN RECEPTOR; CHUK PROTEIN, HUMAN; I KAPPA B KINASE; TESTOSTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN LNCAP; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; CELL NUCLEUS; CYTOPLASM; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ANDROGENS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; HUMANS; I-KAPPA B KINASE; MALE; METRIBOLONE; NF-KAPPA B P50 SUBUNIT; NF-KAPPA B P52 SUBUNIT; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TESTOSTERONE CONGENERS; TRANSCRIPTION FACTOR RELA;

EID: 33947233680     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2006.12.012     Document Type: Article

References (42)

1. Crawford E.D., Eisenberger M.A., McLeod D.G., Spaulding J.T., Benson R., Dorr F.A., Blumenstein B.A., Davis M.A., and Goodman P.J. N. Engl. J. Med. 321 (1989) 419
2. Culine S., and Droz J.P. Ann. Oncol. 11 (2000) 1523
3. Morris M.J., and Scher H.I. Cancer 89 (2000) 1329
4. Coughlin S.S., and Hall I.J. Ann. Epidemiol. 12 (2002) 182
5. Shang Y., Myers M., and Brown M. Mol. Cell 9 (2002) 601
6. Heinlein C.A., and Chang C. Endocr. Rev. 25 (2004) 276
7. Suh J., and Rabson A.B. J. Cell. Biochem. 91 (2004) 100
8. Hayden M.S., and Ghosh S. Genes Dev. 18 (2004) 2195
9. Hoffmann A., and Baltimore D. Immunol. Rev. 210 (2006) 171
10. Pomerantz J.L., and Baltimore D. Mol. Cell 10 (2002) 693
11. Gasparian A.V., Yao Y.J., Kowalczyk D., Lyakh L.A., Karseladze A., Slaga T.J., and Budunova I.V. J. Cell Sci. 115 (2002) 141
12. Suh J., Payvandi F., Edelstein L.C., Amenta P.S., Zong W.X., Gelinas C., and Rabson A.B. Prostate 52 (2002) 183
13. Huang S., Pettaway C.A., Uehara H., Bucana C.D., and Fidler I.J. Oncogene 20 (2001) 4188
14. Lindholm P.F., Bub J., Kaul S., Shidham V.B., and Kajdacsy-Balla A. Clin. Exp. Metastasis 18 (2000) 471
15. Yemelyanov A., Gasparian A., Lindholm P., Dang L., Pierce J.W., Kisseljov F., Karseladze A., and Budunova I. Oncogene 25 (2006) 387
16. Chen C.D., and Sawyers C.L. Mol. Cell. Biol. 22 (2002) 2862
17. Palvimo J.J., Reinikainen P., Ikonen T., Kallio P.J., Moilanen A., and Janne O.A. J. Biol. Chem. 271 (1996) 24151
18. Aarnisalo P., Palvimo J.J., and Janne O.A. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2122
19. Aarnisalo P., Santti H., Poukka H., Palvimo J.J., and Janne O.A. Endocrinology 140 (1999) 3097
20. Cinar B., Yeung F., Konaka H., Mayo M.W., Freeman M.R., Zhau H.E., and Chung L.W. Biochem. J. 379 (2004) 421
21. Altuwaijri S., Lin H.K., Chuang K.H., Lin W.J., Yeh S., Hanchett L.A., Rahman M.M., Kang H.Y., Tsai M.Y., Zhang Y., Yang L., and Chang C. Cancer Res. 63 (2003) 7106
22. Catz S.D., and Johnson J.L. Oncogene 20 (2001) 7342
23. Keller E.T., Chang C., and Ershler W.B. J. Biol. Chem. 271 (1996) 26267
24. Kimura K., Markowski M., Bowen C., and Gelmann E.P. Cancer Res. 61 (2001) 5611
25. Saccani S., Pantano S., and Natoli G. Mol. Cell 11 (2003) 1563
26. Bren G.D., Solan N.J., Miyoshi H., Pennington K.N., Pobst L.J., and Paya C.V. Oncogene 20 (2001) 7722
27. Xiao G., Fong A., and Sun S.C. J. Biol. Chem. 279 (2004) 30099
28. Demicco E.G., Kavanagh K.T., Romieu-Mourez R., Wang X., Shin S.R., Landesman-Bollag E., Seldin D.C., and Sonenshein G.E. Mol. Cell. Biol. 25 (2005) 10136
29. Nonaka M., Horie R., Itoh K., Watanabe T., Yamamoto N., and Yamaoka S. Oncogene 24 (2005) 3976
30. Pallares J., Martinez-Guitarte J.L., Dolcet X., Llobet D., Rue M., Palacios J., Prat J., and Matias-Guiu X. J. Pathol. 204 (2004) 569
31. Perkins N.D. Oncogene 22 (2003) 7553
32. Vacca A., Felli M.P., Palermo R., Di Mario G., Calce A., Di Giovine M., Frati L., Gulino A., and Screpanti I. EMBO J. 25 (2006) 1000
33. Lessard L., Begin L.R., Gleave M.E., Mes-Masson A.M., and Saad F. Br. J. Cancer 93 (2005) 1019
34. Sramkoski R.M., Pretlow II T.G., Giaconia J.M., Pretlow T.P., Schwartz S., Sy M.S., Marengo S.R., Rhim J.S., Zhang D., and Jacobberger J.W. In Vitro Cell. Dev. Biol., Anim. 35 (1999) 403
35. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., Grewal I.S., Cochran A.G., Gordon N.C., Yin J., Starovasnik M.A., and Dixit V.M. Immunity 17 (2002) 515
36. Coope H.J., Atkinson P.G., Huhse B., Belich M., Janzen J., Holman M.J., Klaus G.G., Johnston L.H., and Ley S.C. EMBO J. 21 (2002) 5375
37. Mordmuller B., Krappmann D., Esen M., Wegener E., and Scheidereit C. EMBO Rep. 4 (2003) 82
38. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., Li Z.W., Karin M., Ware C.F., and Green D.R. Immunity 17 (2002) 525
39. Muller J.R., and Siebenlist U. J. Biol. Chem. 278 (2003) 12006
40. Ripple M.O., Henry W.F., Schwarze S.R., Wilding G., and Weindruch R. J. Natl. Cancer Inst. 91 (1999) 1227
41. Coffey R.N., Watson R.W., O'Neill A.J., Mc Eleny K., and Fitzpatrick J.M. Prostate 53 (2002) 300
42. Liptay S., Schmid R.M., Nabel E.G., and Nabel G.J. Mol. Cell. Biol. 14 (1994) 7695